Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer

Julie L. Barone, Sheldon M. Feldman, Alison Estabrook, Paul I. Tartter, Sharon M. Rosenbaum Smith, Susan K. Boolbol

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Sentinel lymph node biopsy (SLNB) is considered a standard of care in the staging of breast cancer. The objective was to examine our experience with reoperative SLNB. Methods: We identified19 patients in our breast cancer database who had a SLNB in the reoperative setting. All 19 patients had undergone previous breast-conserving surgery with either an axillary lymph node dissection or an SLNB. The reoperative sentinel lymph node (SLN) was identified using blue dye, radioisotope, or both. Results: The SLN was identified in 84% of the reoperative cases. Of these successful cases, both blue dye and radioisotope were used in five cases, and radioisotope alone was used in 11 cases. Radioisotope identified the SLN in the 100% of successful SLNB cases (P = .0003). There were 3 unsuccessful cases in which blue dye and radioisotope failed to identify the sentinel node. Conclusions: Reoperative SLNB after previous axillary surgery is technically feasible.

Original languageEnglish (US)
Pages (from-to)491-493
Number of pages3
JournalAmerican Journal of Surgery
Volume194
Issue number4
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Sentinel Lymph Node Biopsy
Radioisotopes
Breast Neoplasms
Coloring Agents
Segmental Mastectomy
Standard of Care
Lymph Node Excision
Databases
Sentinel Lymph Node

Keywords

  • Locally recurrent breast cancer
  • Reoperative sentinel lymph node biopsy

ASJC Scopus subject areas

  • Surgery

Cite this

Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer. / Barone, Julie L.; Feldman, Sheldon M.; Estabrook, Alison; Tartter, Paul I.; Rosenbaum Smith, Sharon M.; Boolbol, Susan K.

In: American Journal of Surgery, Vol. 194, No. 4, 01.10.2007, p. 491-493.

Research output: Contribution to journalArticle

Barone, JL, Feldman, SM, Estabrook, A, Tartter, PI, Rosenbaum Smith, SM & Boolbol, SK 2007, 'Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer', American Journal of Surgery, vol. 194, no. 4, pp. 491-493. https://doi.org/10.1016/j.amjsurg.2007.07.011
Barone, Julie L. ; Feldman, Sheldon M. ; Estabrook, Alison ; Tartter, Paul I. ; Rosenbaum Smith, Sharon M. ; Boolbol, Susan K. / Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer. In: American Journal of Surgery. 2007 ; Vol. 194, No. 4. pp. 491-493.
@article{4a10d41995374943b48c52dfcd5c9b48,
title = "Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer",
abstract = "Background: Sentinel lymph node biopsy (SLNB) is considered a standard of care in the staging of breast cancer. The objective was to examine our experience with reoperative SLNB. Methods: We identified19 patients in our breast cancer database who had a SLNB in the reoperative setting. All 19 patients had undergone previous breast-conserving surgery with either an axillary lymph node dissection or an SLNB. The reoperative sentinel lymph node (SLN) was identified using blue dye, radioisotope, or both. Results: The SLN was identified in 84{\%} of the reoperative cases. Of these successful cases, both blue dye and radioisotope were used in five cases, and radioisotope alone was used in 11 cases. Radioisotope identified the SLN in the 100{\%} of successful SLNB cases (P = .0003). There were 3 unsuccessful cases in which blue dye and radioisotope failed to identify the sentinel node. Conclusions: Reoperative SLNB after previous axillary surgery is technically feasible.",
keywords = "Locally recurrent breast cancer, Reoperative sentinel lymph node biopsy",
author = "Barone, {Julie L.} and Feldman, {Sheldon M.} and Alison Estabrook and Tartter, {Paul I.} and {Rosenbaum Smith}, {Sharon M.} and Boolbol, {Susan K.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1016/j.amjsurg.2007.07.011",
language = "English (US)",
volume = "194",
pages = "491--493",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer

AU - Barone, Julie L.

AU - Feldman, Sheldon M.

AU - Estabrook, Alison

AU - Tartter, Paul I.

AU - Rosenbaum Smith, Sharon M.

AU - Boolbol, Susan K.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Background: Sentinel lymph node biopsy (SLNB) is considered a standard of care in the staging of breast cancer. The objective was to examine our experience with reoperative SLNB. Methods: We identified19 patients in our breast cancer database who had a SLNB in the reoperative setting. All 19 patients had undergone previous breast-conserving surgery with either an axillary lymph node dissection or an SLNB. The reoperative sentinel lymph node (SLN) was identified using blue dye, radioisotope, or both. Results: The SLN was identified in 84% of the reoperative cases. Of these successful cases, both blue dye and radioisotope were used in five cases, and radioisotope alone was used in 11 cases. Radioisotope identified the SLN in the 100% of successful SLNB cases (P = .0003). There were 3 unsuccessful cases in which blue dye and radioisotope failed to identify the sentinel node. Conclusions: Reoperative SLNB after previous axillary surgery is technically feasible.

AB - Background: Sentinel lymph node biopsy (SLNB) is considered a standard of care in the staging of breast cancer. The objective was to examine our experience with reoperative SLNB. Methods: We identified19 patients in our breast cancer database who had a SLNB in the reoperative setting. All 19 patients had undergone previous breast-conserving surgery with either an axillary lymph node dissection or an SLNB. The reoperative sentinel lymph node (SLN) was identified using blue dye, radioisotope, or both. Results: The SLN was identified in 84% of the reoperative cases. Of these successful cases, both blue dye and radioisotope were used in five cases, and radioisotope alone was used in 11 cases. Radioisotope identified the SLN in the 100% of successful SLNB cases (P = .0003). There were 3 unsuccessful cases in which blue dye and radioisotope failed to identify the sentinel node. Conclusions: Reoperative SLNB after previous axillary surgery is technically feasible.

KW - Locally recurrent breast cancer

KW - Reoperative sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=34548451996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548451996&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2007.07.011

DO - 10.1016/j.amjsurg.2007.07.011

M3 - Article

C2 - 17826062

AN - SCOPUS:34548451996

VL - 194

SP - 491

EP - 493

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -